leisure time -WSS

leisure time

author：focus 2025-08-28 08:39:57 - browse：49332

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： FDA approves Sage Therapeutics’ rapid

hotspot

WSS

A rare thyroid diagnosis led to unexpected, all

2 officers injured in shooting in Orlando, police say

Advances in CAR

How to ethically and practically extend health care to all

How to ethically and practically extend health care to all

How to ethically and practically extend health care to all

focus

leisure time

hotspot

Cancer drug shortages should be causing more outrage

Why Novartis is changing the name of its research labs

Heart attack and stroke risk calculators need revising

Florida officials tell state schools to teach AP Psychology 'in its entirety'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Bright Health sells Medicare Advantage business to Molina

FDA approves Sage Therapeutics’ rapid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA approves Sage Therapeutics’ rapid

leisure time

The 10 drugs up first for Medicare price negotiation

FDA approves Sage Therapeutics’ rapid

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Amazon on where the company's health care bets are headed next

What drug price negotiations mean for Medicare Part D

Late stage cancers on the rise after pandemic delayed screenings

hotspot

hotspot

knowledge

hotspot